Feb 24 (Reuters) - Qube Holdings Ltd (QUB) :
- HY REVENUE FROM ORDINARY ACTIVITIES A$1,181.6 MILLION VERSUS A$917.0 MILLION
- INTERIM DIVIDEND PER SHARE (FULLY FRANKED) 3.0 AU CENTS
- HY NET PROFIT AFTER TAX ATTRIBUTABLE A$56.3 MILLION, DOWN 3%
- IN FY22, EXPECTS TO DELIVER STRONG UNDERLYING EARNINGS GROWTH FROM OPERATING DIVISION
- IN FY22, SOLID VOLUMES ARE EXPECTED TO CONTINUE ACROSS MOST PORTS' ACTIVITIES AND BULK COMMODITIES
- IN FY22, EXPECTS A STRONG UNDERLYING EARNINGS CONTRIBUTION FROM PATRICK
- FORECASTING H2 FY22 CAPEX TO BE AROUND A$300 MILLION TO A$400 MILLION
- IN FY22, PROPERTY DIVISION IS EXPECTED TO PRODUCE AN BREAKEVEN UNDERLYING RESULT
- CORPORATE COSTS (EBIT) ARE EXPECTED TO INCREASE IN FY22
- EXPECTS TO DELIVER STRONG UNDERLYING EARNINGS GROWTH IN BOTH NPATA AND EPSA IN FY22 COMPARED TO FY21
- Forums
- ASX - By Stock
- QUB
- News: QUB Qube Posts HY Revenue From Ordinary Activities Of A$1,181.6 Million
QUB
qube holdings limited
Add to My Watchlist
0.00%
!
$4.10

News: QUB Qube Posts HY Revenue From Ordinary Activities Of A$1,181.6 Million
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.10 |
Change
0.000(0.00%) |
Mkt cap ! $7.253B |
Open | High | Low | Value | Volume |
$4.10 | $4.14 | $4.09 | $9.435M | 2.297M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 476 | $4.10 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.12 | 439 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2203 | 4.070 |
5 | 19962 | 4.050 |
1 | 249 | 4.010 |
5 | 9315 | 4.000 |
1 | 1250 | 3.990 |
Price($) | Vol. | No. |
---|---|---|
4.170 | 11990 | 1 |
4.200 | 6350 | 2 |
4.240 | 3654 | 1 |
4.250 | 3614 | 1 |
4.270 | 18000 | 1 |
Last trade - 16.10pm 05/09/2025 (20 minute delay) ? |
Featured News
QUB (ASX) Chart |
The Watchlist
PSC
PROSPECT RESOURCES LIMITED
Sam Hosack, MD & CEO
Sam Hosack
MD & CEO
SPONSORED BY The Market Online